CDMO
CDMO
Revolutionary Startup Aims to Transform Cell and Gene Therapies
BIOT
📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬
Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
BIOT
📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈
Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
BIOT
🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀
Astellas’ Gastric Cancer Treatment Rejected by FDA Blames CDMO
BIOT
📢 Astellas' gastric cancer antibody rejected by FDA due to CDMO issues. Setback for treatment, importance of reliable CDMO highlighted. 😞🔍🏭📉💡
